TLR4 and cancer: Together, our findings previously (28) and in this report suggest that TNFα is essential for an IAP antagonist to treat cancer by inducing cancer cell apoptosis rapidly, and bacterial component LPS can also induce breast cancer cell apoptosis through TLR4 stimulating TNFα production by the host cells.